Cargando…

Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders

BACKGROUND: Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) present with similar movement disorder symptoms but distinct protein aggregates upon pathological examination. OBJECTIVE: Discovery and validation of candidate biomarkers in parkinsonian dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shaochun, Bäckström, David, Forsgren, Lars, Trupp, Miles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198747/ https://www.ncbi.nlm.nih.gov/pubmed/35253777 http://dx.doi.org/10.3233/JPD-213031

Ejemplares similares

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid
por: Boman, Andrea, et al.
Publicado: (2016)

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
por: Sjödin, Simon, et al.
Publicado: (2017)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
por: Starhof, C., et al.
Publicado: (2018)

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS
por: Zhu, Shaochun, et al.
Publicado: (2019)

Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study
por: Bäckström, David, et al.
Publicado: (2022)

Cerebrospinal Fluid Neuropeptide Y Levels in Major Depression and Reported Childhood Trauma
por: Soleimani, Laili, et al.
Publicado: (2014)

Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
por: Yutuc, Eylan, et al.
Publicado: (2021)

Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease
por: Quinn, James P., et al.
Publicado: (2023)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Correction to “Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease”
por: Quinn, James P., et al.
Publicado: (2023)

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017)

Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid
por: Günther, Göran, et al.
Publicado: (2011)

Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes
por: Jurjević, Ivana, et al.
Publicado: (2017)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder
por: Gesell, Felix K, et al.
Publicado: (2013)

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
por: Lobanova, Evgeniia, et al.
Publicado: (2021)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features
por: Griffiths, William J., et al.
Publicado: (2021)

Expression of and correlational patterns among neuroinflammatory, neuropeptide, and neuroendocrine molecules from cerebrospinal fluid in cerebral palsy
por: Goracke-Postle, Cory J., et al.
Publicado: (2021)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
por: Tan, Z, et al.
Publicado: (2015)

Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid
por: Royds, Jonathan, et al.
Publicado: (2020)

Cerebrospinal Fluid Space Alterations in Melancholic Depression
por: Via, Esther, et al.
Publicado: (2012)

Alterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes
por: Endres, Dominique, et al.
Publicado: (2016)

Autonomic Dysfunctions in Parkinsonian Disorders
por: Bae, Hyo-Jin, et al.
Publicado: (2009)

Assessing Bradykinesia in Parkinsonian Disorders
por: Pal, Gian, et al.
Publicado: (2013)

TSPO imaging in parkinsonian disorders
por: Gerhard, Alexander
Publicado: (2016)

Assisted Suicide in Parkinsonian Disorders
por: Nuebling, Georg S., et al.
Publicado: (2021)

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019)

Corrigendum to: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Publicado: (2021)

Potential for intranasal drug delivery to alter cerebrospinal fluid outflow via the nasal turbinate lymphatics
por: Kim, Harold, et al.
Publicado: (2014)

Detection of Protein Aggregates in Brain and Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
por: David, Monique Antoinette, et al.
Publicado: (2014)

Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD
por: Kim, Byung Kil, et al.
Publicado: (2020)

Cerebrospinal fluid metabolite alterations in patients with different etiologies, diagnoses, and prognoses of disorders of consciousness
por: Xu, Long, et al.
Publicado: (2023)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
por: Padayachee, E.R., et al.
Publicado: (2016)

Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
por: Woelke, S., et al.
Publicado: (2020)

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
por: Skachokova, Zhiva, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_02i9l3q8q03o5mmiqvtur1dvlo